EEVIA Stock Overview
Produces and distributes organic bioactive plant extracts in Finland and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Eevia Health Oyj Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.58 |
52 Week High | SEK 3.98 |
52 Week Low | SEK 0.46 |
Beta | 0.96 |
11 Month Change | -6.43% |
3 Month Change | -61.71% |
1 Year Change | -83.23% |
33 Year Change | -96.62% |
5 Year Change | n/a |
Change since IPO | -91.69% |
Recent News & Updates
Recent updates
Shareholder Returns
EEVIA | SE Pharmaceuticals | SE Market | |
---|---|---|---|
7D | -7.0% | -1.8% | -4.2% |
1Y | -83.2% | 73.0% | 12.5% |
Return vs Industry: EEVIA underperformed the Swedish Pharmaceuticals industry which returned 82.3% over the past year.
Return vs Market: EEVIA underperformed the Swedish Market which returned 17% over the past year.
Price Volatility
EEVIA volatility | |
---|---|
EEVIA Average Weekly Movement | 28.5% |
Pharmaceuticals Industry Average Movement | 10.7% |
Market Average Movement | 5.8% |
10% most volatile stocks in SE Market | 12.2% |
10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: EEVIA's share price has been volatile over the past 3 months.
Volatility Over Time: EEVIA's weekly volatility has increased from 19% to 29% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | 19 | Stein Ulve | eeviahealth.com |
Eevia Health Oyj produces and distributes organic bioactive plant extracts in Finland and internationally. The company offers bilberry, lingonberry, chaga-mushroom, pine bark, elderberry, and tart cherry extracts. Its products are used in dietary supplements and food products.
Eevia Health Oyj Fundamentals Summary
EEVIA fundamental statistics | |
---|---|
Market cap | SEK 20.79m |
Earnings (TTM) | -SEK 14.89m |
Revenue (TTM) | SEK 41.20m |
0.5x
P/S Ratio-1.4x
P/E RatioIs EEVIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EEVIA income statement (TTM) | |
---|---|
Revenue | €3.57m |
Cost of Revenue | €1.06m |
Gross Profit | €2.51m |
Other Expenses | €3.80m |
Earnings | -€1.29m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 21, 2024
Earnings per share (EPS) | -0.036 |
Gross Margin | 70.18% |
Net Profit Margin | -36.13% |
Debt/Equity Ratio | 35.1% |
How did EEVIA perform over the long term?
See historical performance and comparison